Renal fibrosis: novel insights into mechanisms and therapeutic targets (original) (raw)

• Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429–1437 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Schlondorff, D. O. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 74, 860–866 (2008).
  Article CAS PubMed Google Scholar
• Chevalier, R. L. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2, 157–168 (2006).
  Article CAS PubMed Google Scholar
• Kaissling, B. & Le Hir, M. The renal cortical interstitium: morphological and functional aspects. Histochem. Cell Biol. 130, 247–262 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ricardo, S. D., van Goor, H. & Eddy, A. A. Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522–3530 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Floege, J., Eitner, F. & Alpers, C. E. A new look at platelet-derived growth factor in renal disease. J. Am. Soc. Nephrol. 19, 12–23 (2008).
  Article CAS PubMed Google Scholar
• Docherty, N. G., O'Sullivan, O. E., Healy, D. A., Fitzpatrick, J. M. & Watson, R. W. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am. J. Physiol. Renal Physiol. 290, F4–F13 (2006).
  Article CAS PubMed Google Scholar
• Kurts, C., Heymann, F., Lukacs-Kornek, V., Boor, P. & Floege, J. Role of T cells and dendritic cells in glomerular immunopathology. Semin. Immunopathol. 29, 317–335 (2007).
  Article CAS PubMed Google Scholar
• Sung, S. S. & Bolton, W. K. T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop. Kidney Int. 77, 393–399 (2010).
  Article PubMed Google Scholar
• Holdsworth, S. R. & Summers, S. A. Role of mast cells in progressive renal diseases. J. Am. Soc. Nephrol. 19, 2254–2261 (2008).
  Article CAS PubMed Google Scholar
• Liu, Y. New insights into epithelial–mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21, 212–222 (2010).
  Article CAS PubMed Google Scholar
• Boor, P., Sebeková, K., Ostendorf, T. & Floege, J. Treatment targets in renal fibrosis. Nephrol. Dial. Transplant. 22, 3391–3407 (2007).
  Article CAS PubMed Google Scholar
• Chang, H. Y. et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA 99, 12877–12882 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sorrell, J. M. & Caplan, A. I. Fibroblasts—a diverse population at the center of it all. Int. Rev. Cell Mol. Biol. 276, 161–214 (2009).
  Article CAS PubMed Google Scholar
• Hinz, B. The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 43, 146–155 (2010).
  Article PubMed Google Scholar
• Eyden, B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct. Pathol. 25, 39–50 (2001).
  Article CAS PubMed Google Scholar
• Ru, Y., Eyden, B., Curry, A., McWilliam, L. J. & Coyne, J. D. Actin filaments in human renal tubulo-interstitial fibrosis: significance for the concept of epithelial–myofibroblast transformation. J. Submicrosc. Cytol. Pathol. 35, 221–233 (2003).
  CAS PubMed Google Scholar
• Muchaneta-Kubara, E. C. & el Nahas, A. M. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol. Dial. Transplant. 12, 904–915 (1997).
  Article CAS PubMed Google Scholar
• Lin, S. L., Kisseleva, T., Brenner, D. A. & Duffield, J. S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617–1627 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Picard, N., Baum, O., Vogetseder, A., Kaissling, B. & Le Hir, M. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem. Cell Biol. 130, 141–155 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313 (2008).
  Article CAS PubMed Google Scholar
• Sommer, M. et al. Abnormal growth and clonal proliferation of fibroblasts in an animal model of unilateral ureteral obstruction. Nephron 82, 39–50 (1999).
  Article CAS PubMed Google Scholar
• Kilarski, W. W., Samolov, B., Petersson, L., Kvanta, A. & Gerwins, P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat. Med. 15, 657–664 (2009).
  Article CAS PubMed Google Scholar
• Rohatgi, R. & Flores, D. Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Curr. Opin. Nephrol. Hypertens. 19, 65–71 (2010).
  Article PubMed PubMed Central Google Scholar
• Li, L. et al. Aberrant planar cell polarity induced by urinary tract obstruction. Am. J. Physiol. Renal Physiol. 297, F1526–F1533 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Fujigaki, Y. et al. Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats. Virchows Arch. 446, 164–176 (2005).
  Article CAS PubMed Google Scholar
• Takeji, M. et al. Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J. Biol. Chem. 281, 40193–40200 (2006).
  Article CAS PubMed Google Scholar
• Taneda, S. et al. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J. Am. Soc. Nephrol. 14, 2544–2555 (2003).
  Article CAS PubMed Google Scholar
• Boor, P. et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol. Dial. Transplant. 22, 1323–1331 (2007).
  Article CAS PubMed Google Scholar
• Ostendorf, T. et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 17, 1054–1062 (2006).
  Article CAS PubMed Google Scholar
• Kliem, V. et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 49, 666–678 (1996).
  Article CAS PubMed Google Scholar
• Alpers, C. E., Seifert, R. A., Hudkins, K. L., Johnson, R. J. & Bowen-Pope, D. F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int. 43, 286–294 (1993).
  Article CAS PubMed Google Scholar
• Hawthorne, T. et al. A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D. Int. J. Clin. Pharmacol. Ther. 46, 236–244 (2008).
  Article CAS PubMed Google Scholar
• Floege, J. et al. Localization of PDGF alpha-receptor in the developing and mature human kidney. Kidney Int. 51, 1140–1150 (1997).
  Article CAS PubMed Google Scholar
• Floege, J., Hudkins, K. L., Davis, C. L., Schwartz, S. M. & Alpers, C. E. Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J. Am. Soc. Nephrol. 9, 211–223 (1998).
  CAS PubMed Google Scholar
• Eitner, F. et al. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J. Am. Soc. Nephrol. 14, 1145–1153 (2003).
  Article CAS PubMed Google Scholar
• Eitner, F. et al. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J. Am. Soc. Nephrol. 13, 910–917 (2002).
  CAS PubMed Google Scholar
• Eitner, F. et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J. Am. Soc. Nephrol. 19, 281–289 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, H. et al. A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat. Genet. 36, 1111–1116 (2004).
  Article CAS PubMed Google Scholar
• Huang, X. R., Chung, A. C., Wang, X. J., Lai, K. N. & Lan, H. Y. Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am. J. Physiol. Renal Physiol. 295, F118–F127 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, X. R., Chung, A. C., Zhou, L., Wang, X. J. & Lan, H. Y. Latent TGF-beta1 protects against crescentic glomerulonephritis. J. Am. Soc. Nephrol. 19, 233–242 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zeisberg, M. Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol. Dial. Transplant. 21, 568–573 (2006).
  Article CAS PubMed Google Scholar
• Zeisberg, M. et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal Physiol. 285, F1060–F1067 (2003).
  Article CAS PubMed Google Scholar
• Zeisberg, M. et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964–968 (2003).
  Article CAS PubMed Google Scholar
• Zeisberg, M., Shah, A. A. & Kalluri, R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280, 8094–8100 (2005).
  Article CAS PubMed Google Scholar
• Yanagita, M. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int. 70, 989–993 (2006).
  Article CAS PubMed Google Scholar
• Tanaka, M. et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J. Clin. Invest. 120, 768–777 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Grgic, I. et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc. Natl Acad. Sci. USA 106, 14518–14523 (2009).
  Article PubMed PubMed Central Google Scholar
• Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544–550 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Krupa, A. et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21, 438–447 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kato, M. et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl Acad. Sci. USA 104, 3432–3437 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Q. et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22, 4126–4135 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Rastaldi, M. P. et al. Epithelial–mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 62, 137–146 (2002).
  Article PubMed Google Scholar
• Hertig, A. et al. Early epithelial phenotypic changes predict graft fibrosis. J. Am. Soc. Nephrol. 19, 1584–1591 (2008).
  Article PubMed PubMed Central Google Scholar
• Liu, Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 1–12 (2004).
  Article CAS PubMed Google Scholar
• Li, L., Zepeda-Orozco, D., Black, R. & Lin, F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am. J. Pathol. 176, 1767–1778 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Docherty, N. G. et al. Increased E-cadherin expression in the ligated kidney following unilateral ureteric obstruction. Kidney Int. 75, 205–213 (2009).
  Article CAS PubMed Google Scholar
• Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341–350 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Humphreys, B. D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284–291 (2008).
  Article CAS PubMed Google Scholar
• Faulkner, J. L., Szcykalski, L. M., Springer, F. & Barnes, J. L. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am. J. Pathol. 167, 1193–1205 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sheerin, N. S. & Sacks, S. H. Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin. Exp. Immunol. 130, 1–3 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Rangan, G. K., Pippin, J. W., Coombes, J. D. & Couser, W. G. C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria. Kidney Int. 67, 492–503 (2005).
  Article CAS PubMed Google Scholar
• Rangan, G. K., Pippin, J. W. & Couser, W. G. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int. 66, 1838–1848 (2004).
  Article CAS PubMed Google Scholar
• Boor, P. et al. Complement C5 mediates experimental tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 18, 1508–1515 (2007).
  Article CAS PubMed Google Scholar
• Pan, H. et al. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. Am. J. Physiol. Renal Physiol. 296, F496–F504 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120, 1084–1096 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kume, S. et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 120, 1043–1055 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cybulsky, A. V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int. 77, 187–193 (2010).
  Article CAS PubMed Google Scholar
• Inagi, R. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp. Nephrol. 112, e1–e9 (2009).
  Article PubMed Google Scholar
• Periyasamy-Thandavan, S., Jiang, M., Schoenlein, P. & Dong, Z. Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am. J. Physiol. Renal Physiol. 297, F244–F256 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Periyasamy-Thandavan, S. et al. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int. 74, 631–640 (2008).
  Article CAS PubMed Google Scholar
• Pallet, N. et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy 4, 783–791 (2008).
  Article CAS PubMed Google Scholar
• Gozuacik, D. et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ. 15, 1875–1886 (2008).
  Article CAS PubMed Google Scholar
• Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16, 535–543 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Menke, J. et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J. Clin. Invest. 119, 2330–2342 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ruan, X. Z., Varghese, Z. & Moorhead, J. F. An update on the lipid nephrotoxicity hypothesis. Nat. Rev. Nephrol. 5, 713–721 (2009).
  Article CAS PubMed Google Scholar
• Cho, K. H., Kim, H. J., Kamanna, V. S. & Vaziri, N. D. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim. Biophys. Acta 1800, 6–15 (2010).
  Article CAS PubMed Google Scholar
• Cho, K. H., Kim, H. J., Rodriguez-Iturbe, B. & Vaziri, N. D. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am. J. Physiol. Renal Physiol. 297, F106–F113 (2009).
  Article CAS PubMed Google Scholar
• Kim, H. J., Moradi, H., Yuan, J., Norris, K. & Vaziri, N. D. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 296, F1297–F1306 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, J. et al. Peroxisome proliferator-activated receptors and renal diseases. Front. Biosci. 14, 995–1009 (2009).
  Article CAS Google Scholar
• Toblli, J. E. et al. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol. Dial. Transplant. 24, 2384–2391 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kawai, T. et al. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab. Invest. 89, 47–58 (2009).
  Article CAS PubMed Google Scholar
• Higgins, D. F., Kimura, K., Iwano, M. & Haase, V. H. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7, 1128–1132 (2008).
  Article CAS PubMed Google Scholar
• Kimura, K. et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am. J. Physiol. Renal Physiol. 295, F1023–F1029 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810–3820 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282–2287 (2008).
  Article PubMed PubMed Central Google Scholar
• Li, J., Qu, X. & Bertram, J. F. Endothelial–myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 175, 1380–1388 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. J. et al. The aging kidney. Kidney Int. 74, 710–720 (2008).
  Article CAS PubMed Google Scholar
• Wilkinson, L. et al. Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice. Kidney Int. 76, 1161–1171 (2009).
  Article PubMed Google Scholar
• Hakroush, S. et al. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am. J. Pathol. 175, 1883–1895 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sakai, N. et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl Acad. Sci. USA 103, 14098–14103 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Niedermeier, M. et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl Acad. Sci. USA 106, 17892–17897 (2009).
  Article PubMed PubMed Central Google Scholar
• Sakai, N. et al. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum. Pathol. 41, 672–678 (2010).
  Article CAS PubMed Google Scholar
• Pilling, D., Fan, T., Huang, D., Kaul, B. & Gomer, R. H. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4, e7475 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wynn, T. A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583–594 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H. & Pilling, D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J. Leukoc. Biol. 83, 1323–1333 (2008).
  Article CAS PubMed Google Scholar
• Lin, S. L., Castaño, A. P., Nowlin, B. T., Lupher, M. L. Jr & Duffield, J. S. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J. Immunol. 183, 6733–6743 (2009).
  Article CAS PubMed Google Scholar
• Roufosse, C. et al. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J. Am. Soc. Nephrol. 17, 775–782 (2006).
  Article CAS PubMed Google Scholar
• Broekema, M. et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J. Am. Soc. Nephrol. 18, 165–175 (2007).
  Article CAS PubMed Google Scholar
• Henderson, N. C. et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am. J. Pathol. 172, 288–298 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Henderson, N. C. & Sethi, T. The regulation of inflammation by galectin-3. Immunol. Rev. 230, 160–171 (2009).
  Article CAS PubMed Google Scholar
• Ma, F. Y., Liu, J., Kitching, A. R., Manthey, C. L. & Nikolic-Paterson, D. J. Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney. Am. J. Physiol. Renal Physiol. 296, F177–F185 (2009).
  Article CAS PubMed Google Scholar
• Lin, S. L. et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc. Natl Acad. Sci. USA 107, 4194–4199 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Nishida, M. & Hamaoka, K. Macrophage phenotype and renal fibrosis in obstructive nephropathy. Nephron Exp. Nephrol. 110, e31–e36 (2008).
  Article PubMed Google Scholar
• Wang, Y. et al. By homing to the kidney, activated macrophages potently exacerbate renal injury. Am. J. Pathol. 172, 1491–1499 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Nishida, M. et al. Adoptive transfer of macrophages ameliorates renal fibrosis in mice. Biochem. Biophys. Res. Commun. 332, 11–16 (2005).
  Article CAS PubMed Google Scholar
• Krüger, T. et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15, 613–621 (2004).
  Article PubMed Google Scholar
• Macconi, D. et al. Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J. Am. Soc. Nephrol. 20, 123–130 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Heymann, F. et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J. Clin. Invest. 119, 1286–1297 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sakamoto, I. et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 75, 828–838 (2009).
  Article CAS PubMed Google Scholar
• Matsui, K. et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J. Am. Soc. Nephrol. 14, 1981–1989 (2003).
  Article CAS PubMed Google Scholar
• Kriz, W. & LeHir, M. Pathways to nephron loss starting from glomerular diseases—insights from animal models. Kidney Int. 67, 404–419 (2005).
  Article PubMed Google Scholar
• Zhang, T. et al. Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton) 13, 128–138 (2008).
  Article CAS Google Scholar
• Zhang, T. et al. Functional, histological and biochemical consequences of renal lymph disorder in mononephrectomized rats. J. Nephrol. 22, 109–116 (2009).
  CAS PubMed Google Scholar
• Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603–612 (2004).
  Article CAS PubMed Google Scholar
• Stuht, S. et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am. J. Transplant. 7, 377–384 (2007).
  Article CAS PubMed Google Scholar
• El-Koraie, A. F., Baddour, N. M., Adam, A. G., El Kashef, E. H. & El Nahas, A. M. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides. Kidney Int. 60, 167–172 (2001).
  Article CAS PubMed Google Scholar
• Roberts, I. S. & Brenchley, P. E. Mast cells: the forgotten cells of renal fibrosis. J. Clin. Pathol. 53, 858–862 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kondo, S. et al. Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12, 1668–1676 (2001).
  CAS PubMed Google Scholar
• Timoshanko, J. R., Kitching, R., Semple, T. J., Tipping, P. G. & Holdsworth, S. R. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 17, 150–159 (2006).
  Article CAS PubMed Google Scholar
• Kanamaru, Y. et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J. Immunol. 176, 5607–5615 (2006).
  Article CAS PubMed Google Scholar
• Miyazawa, S. et al. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int. 65, 2228–2237 (2004).
  Article PubMed Google Scholar
• Hochegger, K. et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 35, 3074–3082 (2005).
  Article CAS PubMed Google Scholar
• Kim, D. H. et al. Mast cells decrease renal fibrosis in unilateral ureteral obstruction. Kidney Int. 75, 1031–1038 (2009).
  Article CAS PubMed Google Scholar
• Silver, R. B. et al. Mast cells: a unique source of renin. Proc. Natl Acad. Sci. USA 101, 13607–13612 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Fan, Y. Y. et al. Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. J. Pharmacol. Sci. 111, 82–90 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Shweke, N. et al. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am. J. Pathol. 173, 631–642 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, L. et al. Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int. 76, 383–394 (2009).
  Article CAS PubMed Google Scholar
• Abrass, C. K., Hansen, K. M. & Patton, B. L. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am. J. Pathol. 176, 839–849 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Xie, P. et al. C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J. Am. Soc. Nephrol. 20, 807–819 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ramachandra Rao, S. P. et al. Pirfenidone is renoprotective in diabetic kidney disease. J. Am. Soc. Nephrol. 20, 1765–1775 (2009).
  Article CAS Google Scholar
• Takakuta, K. et al. Renoprotective properties of pirfenidone in subtotally nephrectomized rats. Eur. J. Pharmacol. 629, 118–124 (2010).
  Article CAS PubMed Google Scholar
• Cho, M. E. & Kopp, J. B. Pirfenidone: an anti-fibrotic therapy for progressive kidney disease. Expert Opin. Investig. Drugs 19, 275–283 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, M. E., Smith, D. C., Branton, M. H., Penzak, S. R. & Kopp, J. B. Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 2, 906–913 (2007).
  Article CAS PubMed Google Scholar
• Cook, H. T. The origin of renal fibroblasts and progression of kidney disease. Am. J. Pathol. 176, 22–24 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Little, M. H. & Bertram, J. F. Is there such a thing as a renal stem cell? J. Am. Soc. Nephrol. 20, 2112–2117 (2009).
  Article CAS PubMed Google Scholar
• Hopkins, C., Li, J., Rae, F. & Little, M. H. Stem cell options for kidney disease. J. Pathol. 217, 265–281 (2009).
  Article CAS PubMed Google Scholar
• Psihogios, N. G. et al. Evaluation of tubulointerstitial lesions' severity in patients with glomerulonephritides: an NMR-based metabonomic study. J. Proteome Res. 6, 3760–3770 (2007).
  Article CAS PubMed Google Scholar
• Nickolas, T. L., Barasch, J. & Devarajan, P. Biomarkers in acute and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 17, 127–132 (2008).
  Article CAS PubMed Google Scholar
• Tanaka, T. et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am. J. Pathol. 174, 1203–1211 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yamamoto, T. et al. Renal L-type fatty acid—binding protein in acute ischemic injury. J. Am. Soc. Nephrol. 18, 2894–2902 (2007).
  Article CAS PubMed Google Scholar
• Negishi, K. et al. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int. 73, 1374–1384 (2008).
  Article CAS PubMed Google Scholar
• Miranda, K. C. et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 78, 191–199 (2010).
  Article PubMed PubMed Central Google Scholar
• Sato, Y. et al. Urine podocyte mRNAs mark progression of renal disease. J. Am. Soc. Nephrol. 20, 1041–1052 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hartono, C., Muthukumar, T. & Suthanthiran, M. Noninvasive diagnosis of acute rejection of renal allografts. Curr. Opin. Organ Transplant. 15, 35–41 (2010).
  Article PubMed PubMed Central Google Scholar
• Ghoul, B. E. et al. Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist. Clin. J. Am. Soc. Nephrol. 5, 205–210 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ju, W. et al. Renal gene and protein expression signatures for prediction of kidney disease progression. Am. J. Pathol. 174, 2073–2085 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26, 431–442 (2008).
  Article CAS PubMed Google Scholar
• Choi, H. S. et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, L. K. et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol. Dial. Transplant. 24, 3024–3032 (2009).
  Article CAS PubMed Google Scholar
• Li, Y. et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J. Am. Soc. Nephrol. 20, 1907–1918 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, G. et al. A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis. J. Biol. Chem. 284, 29050–29064 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pang, M. et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am. J. Physiol. Renal Physiol. 297, F996–F1005 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Noh, H. et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am. J. Physiol. Renal Physiol. 297, F729–F739 (2009).
  Article CAS PubMed Google Scholar
• Grande, M. T. et al. Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation. World J. Urol. doi:10.1007/s00345-009-0399-8.
• Grande, M. T. et al. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int. 77, 509–518 (2010).
  Article CAS PubMed Google Scholar
• Liao, T. D. et al. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research. Hypertension 55, 459–467 (2010).
  Article CAS PubMed Google Scholar
• Kassiri, Z. et al. Loss of TIMP3 enhances interstitial nephritis and fibrosis. J. Am. Soc. Nephrol. 20, 1223–1235 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Jung, G. S. et al. The orphan nuclear receptor SHP attenuates renal fibrosis. J. Am. Soc. Nephrol. 20, 2162–2170 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hewitson, T. D. et al. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology 148, 660–669 (2007).
  Article CAS PubMed Google Scholar
• Teerlink, J. R. et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373, 1429–1439 (2009).
  Article CAS PubMed Google Scholar
• Yuen, D. A. et al. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS ONE 5, e9543 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Benigni, A., Morigi, M. & Remuzzi, G. Kidney regeneration. Lancet 375, 1310–1317 (2010).
  Article CAS PubMed Google Scholar
• Sakairi, T. et al. Nestin expression in the kidney with an obstructed ureter. Kidney Int. 72, 307–318 (2007).
  Article CAS PubMed Google Scholar
• Nguyen, T. Q. et al. CTGF inhibits BMP-7 signaling in diabetic nephropathy. J. Am. Soc. Nephrol. 19, 2098–2107 (2008).
  Article CAS PubMed PubMed Central Google Scholar